| Home | E-Submission | Sitemap | Contact Us |  
J Neurocrit Care > Browse Articles > J Neurocrit Care



Successful treatment with rituximab in a patient with lupus cerebritis and posterior reversible encephalopathy syndrome: a case report
Saemi Choi, Young Seo Kim
J Neurocrit Care. 2021;14(2):103-108.   Published online December 24, 2021
doi: https://doi.org/10.18700/jnc.210028
                  CrossRef - TDM            
Normal Magnetic Resonance Perfusion Imaging and Atypical Posterior Reversible Encephalopathy Syndrome in Chronic Kidney Disease
Yerim Kim, Yong Soo Shim
J Neurocrit Care. 2017;10(1):41-45.   Published online April 18, 2017
doi: https://doi.org/10.18700/jnc.170003
                  CrossRef - TDM            
Phenylephrine Induced Posterior Reversible Encephalopathy Syndrome during Resection of Solitary Pulmonary Nodule
Soon Ho Hong, Yun Kyung Park, Bora Yoon, Kee Ook Lee, Yong-Duk Kim, Sang-Jun Na
J Neurocrit Care. 2017;10(1):32-35.   Published online June 28, 2017
doi: https://doi.org/10.18700/jnc.170005
                  CrossRef - TDM            
A Case of Leuprolide-Induced Posterior Reversible Encephalopathy Syndrome
Chae Young Lee, Sung-Hee Hwang, Seong Sook Hong, San Jung, Yang-Ki Minn, Seok-Beom Kwon
J Neurocrit Care. 2016;9(2):174-177.   Published online November 18, 2016
doi: https://doi.org/10.18700/jnc.160071
                  CrossRef - TDM               Cited By 1
Posterior Reversible Encephalopathy Syndrome Due to Primary Reversible Cerebral Vasoconstriction Syndrome
Yun Ho Choi, MD, Yu Na Cho, MD, Won Ko, MD, Chul Hyoung Lyoo, MD, PhD, Won-Joo Kim, MD, PhD and Young-Chul Choi, MD, PhD
J Neurocrit Care. 2012;5(2):61-64.
      
1 |
E-Submission
Endnote Style File
Endnote Style File
Email Alert
Author's Index
Supranuclear oculomotor palsy in cerebral venous sinus thrombosis: a case report. J Neurocrit Care. 2021;14:113-116
The author of the accepted manuscript will receive two mugs, printed with an abstract design. We look forward to your continued interest in and support for this journal.
Korean Neurocritical Care Society

First decision

19 Days

Publication after acceptance

57 Days

Submission to publication

109 Days

Acceptance rate

48 %

*Last 12 months

Editorial Office
88, Olympic-ro 43-gil, Songpa-gu, Seoul, Korea
TEL : +82-2-3010-3440    FAX : +82-2-474-4691    E-mail : office@e-jnc.org

Copyright© Korean Neurocritical Care Society.                Developed in M2PI